Equities analysts forecast that II-VI Incorporated (NASDAQ:IIVI) will announce $0.36 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for II-VI’s earnings, with the lowest EPS estimate coming in at $0.34 and the highest estimate coming in at $0.37. II-VI posted earnings of $0.35 per share in the same quarter last year, which suggests a positive year-over-year growth rate of 2.9%. The business is scheduled to report its next quarterly earnings results on Tuesday, October 24th.

On average, analysts expect that II-VI will report full year earnings of $1.92 per share for the current fiscal year, with EPS estimates ranging from $1.56 to $2.28. For the next fiscal year, analysts forecast that the business will report earnings of $2.57 per share, with EPS estimates ranging from $2.14 to $3.00. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research analysts that cover II-VI.

II-VI (NASDAQ:IIVI) last posted its quarterly earnings data on Monday, August 7th. The scientific and technical instruments company reported $0.50 EPS for the quarter, beating the Zacks’ consensus estimate of $0.33 by $0.17. II-VI had a net margin of 9.80% and a return on equity of 12.94%. The company had revenue of $273.70 million for the quarter, compared to analyst estimates of $249.90 million. During the same period in the prior year, the firm posted $0.40 EPS. The company’s quarterly revenue was up 13.4% on a year-over-year basis.

A number of brokerages have recently commented on IIVI. Benchmark Co. boosted their target price on shares of II-VI from $40.00 to $44.00 and gave the company a “buy” rating in a report on Tuesday, August 8th. Northland Securities set a $45.00 price target on II-VI and gave the stock a “buy” rating in a research report on Monday, August 7th. Craig Hallum started coverage on II-VI in a research report on Monday, July 24th. They issued a “buy” rating and a $50.00 price target for the company. BidaskClub raised II-VI from a “hold” rating to a “buy” rating in a research report on Wednesday, July 19th. Finally, Needham & Company LLC boosted their target price on II-VI from $38.00 to $40.00 and gave the stock a “buy” rating in a research report on Wednesday, June 21st. One analyst has rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $44.92.

II-VI (NASDAQ:IIVI) opened at 41.30 on Wednesday. The company’s 50 day moving average is $38.64 and its 200-day moving average is $35.31. II-VI has a 52-week low of $25.05 and a 52-week high of $42.50. The firm has a market cap of $2.61 billion, a P/E ratio of 27.91 and a beta of 0.10.

TRADEMARK VIOLATION WARNING: This news story was first published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another site, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this news story can be read at https://www.americanbankingnews.com/2017/10/11/zacks-brokerages-anticipate-ii-vi-incorporated-iivi-will-announce-earnings-of-0-36-per-share.html.

In other II-VI news, Director Francis J. Kramer sold 25,000 shares of the stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $42.00, for a total value of $1,050,000.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 3.80% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of IIVI. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of II-VI by 91.7% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,764 shares of the scientific and technical instruments company’s stock worth $100,000 after buying an additional 1,322 shares in the last quarter. UBS Asset Management Americas Inc. boosted its position in II-VI by 94.5% during the first quarter. UBS Asset Management Americas Inc. now owns 34,030 shares of the scientific and technical instruments company’s stock valued at $1,227,000 after purchasing an additional 16,532 shares in the last quarter. Karp Capital Management Corp bought a new stake in II-VI during the first quarter valued at about $786,000. Parametric Portfolio Associates LLC boosted its position in II-VI by 14.5% during the first quarter. Parametric Portfolio Associates LLC now owns 175,546 shares of the scientific and technical instruments company’s stock valued at $6,328,000 after purchasing an additional 22,204 shares in the last quarter. Finally, Mutual of America Capital Management LLC bought a new stake in II-VI during the first quarter valued at about $180,000. 78.25% of the stock is currently owned by institutional investors and hedge funds.

II-VI Company Profile

II-VI Incorporated develops and manufactures engineered materials, optoelectronic components and products. The Company has three segments: II-VI Laser Solutions, II-VI Photonics and II-VI Performance Products. The II-VI Laser Solutions segment designs, manufactures and markets optical and electro-optical components and materials sold under the II-VI Infrared brand name and used in carbon dioxide (CO2) lasers, fiber-delivered beam delivery systems and processing tools and direct diode lasers for industrial lasers sold under the II-VI HIGHYAG and II-VI Laser Enterprise brand names.

Get a free copy of the Zacks research report on II-VI (IIVI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for II-VI (NASDAQ:IIVI)

Receive News & Ratings for II-VI Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for II-VI Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.